Enabling rapid vaccine development through manufacturing innovation and process efficiency

The global effort to fight COVID saw the fastest vaccine rollout of all time, saving millions of lives. With the ongoing demand for COVID vaccines and the threat of future pandemics, maintaining and building global vaccine manufacturing capacity has never been more important.

In March, Vaccine Insights and Thermo Fisher Scientific will bring together a panel of vaccine manufacturing experts to discuss how they are meeting the need for rapid, flexible, and affordable vaccine production – and what we can learn from the accelerated development and manufacture of SARS-CoV-2 vaccines.

Attend this webinar to learn about:

• Key bottlenecks in scaling up vaccine production and how they can be overcome
• Increasing process intensification
• Challenges and key learnings from manufacturing new modalities e.g., mRNA
• Valuable technology innovations, particularly in downstream bioprocessing

Cleo Kontoravdi

Professor of Biological Systems Engineering Imperial College London

Murali Muralidhara

Chief Manufacturing Officer, RVAC Medicines

Sirat Sikka

Field Applications Scientist, Nucleic Acid Therapeutics, Thermo Fisher Scientific

Hao Chen

AVP, Vaccines Process R&D, Merck